Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1997 Apr;52(4):318–321. doi: 10.1136/thx.52.4.318

Epidemiology of chronic Pseudomonas aeruginosa infections in the airways of lung transplant recipients with cystic fibrosis

S Walter, P Gudowius, J Bosshammer, U Romling, H Weissbrodt, W Schurmann, H von der Hardt, B Tummler
PMCID: PMC1758546  PMID: 9196512

Abstract

BACKGROUND: The source of airway colonisation with Pseudomonas aeruginosa is not well defined in patients with cystic fibrosis after lung transplantation. Using a DNA-based typing system a study was undertaken to investigate whether lung transplant recipients acquired new strains of P aeruginosa or retained those they had before transplantation. METHODS: Seventy four P aeruginosa isolates taken before and after transplantation were analysed from 11 patients with cystic fibrosis who had undergone lung transplantation in the Medical School of Hannover between 1988 and 1994. The genetic relatedness of the 74 P aeruginosa strains was evaluated from macrorestriction fragment pattern similarity. RESULTS: Each of the 11 lung transplant recipients harboured one identical P aeruginosa clone before and after transplantation. The airways of four of the 11 patients were preoperatively colonised by two or three different clones, but six months after transplantation only one clone was detectable. CONCLUSIONS: These results show that there is no change in the P aeruginosa population in the airways of lung transplant recipients before and after transplantation and it is assumed that the chronic drainage of P aeruginosa into the lung allografts is caused by the bacterial reservoir in the paranasal sinuses and the trachea. 






Full Text

The Full Text of this article is available as a PDF (129.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cooper J. D., Billingham M., Egan T., Hertz M. I., Higenbottam T., Lynch J., Mauer J., Paradis I., Patterson G. A., Smith C. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 1993 Sep-Oct;12(5):713–716. [PubMed] [Google Scholar]
  2. Flume P. A., Egan T. M., Paradowski L. J., Detterbeck F. C., Thompson J. T., Yankaskas J. R. Infectious complications of lung transplantation. Impact of cystic fibrosis. Am J Respir Crit Care Med. 1994 Jun;149(6):1601–1607. doi: 10.1164/ajrccm.149.6.7516251. [DOI] [PubMed] [Google Scholar]
  3. Kahn F. W., Jones J. M. Diagnosing bacterial respiratory infection by bronchoalveolar lavage. J Infect Dis. 1987 May;155(5):862–869. doi: 10.1093/infdis/155.5.862. [DOI] [PubMed] [Google Scholar]
  4. Knowles M. R., Stutts M. J., Spock A., Fischer N., Gatzy J. T., Boucher R. C. Abnormal ion permeation through cystic fibrosis respiratory epithelium. Science. 1983 Sep 9;221(4615):1067–1070. doi: 10.1126/science.6308769. [DOI] [PubMed] [Google Scholar]
  5. Lode H., Schaberg T., Raffenberg M., Mauch H. Diagnostic problems in lower respiratory tract infections. J Antimicrob Chemother. 1993 Jul;32 (Suppl A):29–37. doi: 10.1093/jac/32.suppl_a.29. [DOI] [PubMed] [Google Scholar]
  6. Madden B. P., Hodson M. E., Tsang V., Radley-Smith R., Khaghani A., Yacoub M. Y. Intermediate-term results of heart-lung transplantation for cystic fibrosis. Lancet. 1992 Jun 27;339(8809):1583–1587. doi: 10.1016/0140-6736(92)91842-v. [DOI] [PubMed] [Google Scholar]
  7. Moss R. B., King V. V. Management of sinusitis in cystic fibrosis by endoscopic surgery and serial antimicrobial lavage. Reduction in recurrence requiring surgery. Arch Otolaryngol Head Neck Surg. 1995 May;121(5):566–572. doi: 10.1001/archotol.1995.01890050058011. [DOI] [PubMed] [Google Scholar]
  8. Ogle J. W., Janda J. M., Woods D. E., Vasil M. L. Characterization and use of a DNA probe as an epidemiological marker for Pseudomonas aeruginosa. J Infect Dis. 1987 Jan;155(1):119–126. doi: 10.1093/infdis/155.1.119. [DOI] [PubMed] [Google Scholar]
  9. Pritchard A. E., Vasil M. L. Possible insertion sequences in a mosaic genome organization upstream of the exotoxin A gene in Pseudomonas aeruginosa. J Bacteriol. 1990 Apr;172(4):2020–2028. doi: 10.1128/jb.172.4.2020-2028.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Römling U., Fiedler B., Bosshammer J., Grothues D., Greipel J., von der Hardt H., Tümmler B. Epidemiology of chronic Pseudomonas aeruginosa infections in cystic fibrosis. J Infect Dis. 1994 Dec;170(6):1616–1621. doi: 10.1093/infdis/170.6.1616. [DOI] [PubMed] [Google Scholar]
  11. Schmidt K. D., Tümmler B., Römling U. Comparative genome mapping of Pseudomonas aeruginosa PAO with P. aeruginosa C, which belongs to a major clone in cystic fibrosis patients and aquatic habitats. J Bacteriol. 1996 Jan;178(1):85–93. doi: 10.1128/jb.178.1.85-93.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Shankar S., Fulsham L., Read R. C., Theodoropoulos S., Cole P. J., Madden B., Yacoub M. Mucociliary function after lung transplantation. Transplant Proc. 1991 Feb;23(1 Pt 2):1222–1223. [PubMed] [Google Scholar]
  13. Sokol P. A., Luan M. Z., Storey D. G., Thirukkumaran P. Genetic rearrangement associated with in vivo mucoid conversion of Pseudomonas aeruginosa PAO is due to insertion elements. J Bacteriol. 1994 Feb;176(3):553–562. doi: 10.1128/jb.176.3.553-562.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Stammberger H., Wolf G. Headaches and sinus disease: the endoscopic approach. Ann Otol Rhinol Laryngol Suppl. 1988 Sep-Oct;134:3–23. doi: 10.1177/00034894880970s501. [DOI] [PubMed] [Google Scholar]
  15. Steinbach S., Sun L., Jiang R. Z., Flume P., Gilligan P., Egan T. M., Goldstein R. Transmissibility of Pseudomonas cepacia infection in clinic patients and lung-transplant recipients with cystic fibrosis. N Engl J Med. 1994 Oct 13;331(15):981–987. doi: 10.1056/NEJM199410133311504. [DOI] [PubMed] [Google Scholar]
  16. Sundaresan S., Trulock E. P., Mohanakumar T., Cooper J. D., Patterson G. A. Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Washington University Lung Transplant Group. Ann Thorac Surg. 1995 Nov;60(5):1341–1347. doi: 10.1016/0003-4975(95)00751-6. [DOI] [PubMed] [Google Scholar]
  17. Taylor C. J., McGaw J., Howden R., Duerden B. I., Baxter P. S. Bacterial reservoirs in cystic fibrosis. Arch Dis Child. 1990 Feb;65(2):175–177. doi: 10.1136/adc.65.2.175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Thorpe J. E., Baughman R. P., Frame P. T., Wesseler T. A., Staneck J. L. Bronchoalveolar lavage for diagnosing acute bacterial pneumonia. J Infect Dis. 1987 May;155(5):855–861. doi: 10.1093/infdis/155.5.855. [DOI] [PubMed] [Google Scholar]
  19. Tsang V., Hodson M. E., Yacoub M. H. Lung transplantation for cystic fibrosis. Br Med Bull. 1992 Oct;48(4):949–971. doi: 10.1093/oxfordjournals.bmb.a072587. [DOI] [PubMed] [Google Scholar]
  20. Tsang V., Pitt T. L., Kaufmann M. E., Gaya H., Hodson M. E., Yacoub M. Colonisation of lung allografts with Pseudomonas aeruginosa in heart-lung transplant recipients with cystic fibrosis. Thorax. 1994 Jul;49(7):721–722. doi: 10.1136/thx.49.7.721. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Umetsu D. T., Moss R. B., King V. V., Lewiston N. J. Sinus disease in patients with severe cystic fibrosis: relation to pulmonary exacerbation. Lancet. 1990 May 5;335(8697):1077–1078. doi: 10.1016/0140-6736(90)92642-u. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES